Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 22, 2015 9:34 PM ET

Healthcare Equipment and Supplies

Company Overview of Rochester Medical Corporation

Company Overview

Rochester Medical Corporation engages in the development, manufacture, and marketing of PVC-free and latex-free urinary continence and urine drainage care products for the home and acute care markets. Its home care products include silicone male external catheters (MECs) under the UltraFlex, Pop-On, Wide Band, Natural, Clear Advantage, Transfix, and Spirit names for managing male urinary incontinence; latex MECs under the Freedom and Freedom Plus names for managing male urinary incontinence; intermittent catheters, such as standard, antibacterial, hydrophilic, and antibacterial personal catheters in various diameters for male, female, and pediatric use; and the FemSoft Insert, a liquid-fille...

One Rochester Medical Drive

Stewartville, MN 55976-1647

United States

Founded in 1988

344 Employees

Phone:

507-533-9600

Fax:

507-533-9725

Key Executives for Rochester Medical Corporation

Co-Founder, Executive Chairman and Chief Executive Officer
Age: 70
President and Director
Co-Founder and Vice President of Production Technologies
Age: 58
Chief Financial Officer, Chief Accounting Officer and Director
Age: 50
Vice President and Treasurer
Age: 47
Compensation as of Fiscal Year 2014.

Rochester Medical Corporation Key Developments

Rochester Medical Corporation Announces Management Changes

Pursuant to the terms of the merger agreement the members of the board of directors of Merger Sub immediately prior to the effective time became the members of the Board of Directors of Rochester Medical Corporation. These members include Peter R. Curry, Jean F. Holloway, Christopher S. Holland, and John H. Weiland. Also at the effective time, the officers of Merger Sub immediately prior to the Effective Time became the officers of Rochester Medical. These officers include: Peter R. Curry, President; John H. Weiland, Vice President; Christopher S. Holland, Vice President; Jean F. Holloway, Vice President and Secretary; Scott T. Lowry, Vice President and Treasurer; and Richard C. Rosenzweig, Vice President and Assistant Secretary.

Rochester Medical Corporation(NasdaqGM:ROCM) dropped from NASDAQ Composite Index

Rochester Medical Corporation will be removed from NASDAQ Composite Index.

Rochester Medical Corporation, Special/Extraordinary Shareholders Meeting, Nov 13, 2013

Rochester Medical Corporation, Special/Extraordinary Shareholders Meeting, Nov 13, 2013., at 14:00 Central Standard Time. Location: offices of Dorsey & Whitney LLP. Agenda: To consider and vote on the proposal to adopt the previously announced agreement to be acquired by a subsidiary of C.R. Bard, Inc.

Similar Private Companies By Industry

Company Name Region
Serica Technologies, Inc. United States
EmboMedics, Inc. United States
Bartron Medical Imaging Inc. United States
Alpha Bedding LLC United States
Phoenix Laser Systems, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Rochester Medical Corporation, please visit www.rocm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.